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Abstract 
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The aim of this study is to compare the clinical characteristics of three groups 
of patients in treatment for cocaine dependence: patients without any psychotic 
symptoms (NS), patients with transient psychotic symptoms (PS) and patients 
with cocaine- induced psychotic disorder (CIPD). An observational and 
retrospective study of 150 cocaine-dependent patients undergoing treatment in 
the Drug Unit of the Psychiatry Department of University Hospital Vall d'Hebron 
in Barcelona (Spain) using these three groups, NS, PS and CIPD, was performed. All 
patients were evaluated with the PRISM interview. ANOVA, Chi-square tests and 
multivariate multinomial regression analysis were used to perform statistical 
analyses. Seven patients with a primary psychotic disorder were discharged. 
Forty-six patients (32.1%) did not report any psychotic symptoms. Ninety-seven 
patients (67.9%) presented with a history of any cocaine- induced psychotic 
symptom and were considered as the cocaine-induced psychotic (CIP) group. 
Among them, 39 (27.3%) were included in the PS group, and 58 (40.6%) were 
included in the CIPD group. A history of imprisonment was found significantly 
more frequently in the PS than the NS group. The distribution of age at onset 
of dependence, lifetime cannabis abuse or dependence and imprisonment were 
significantly different between the NS and CIPD groups. We conclude that in 
cocaine- dependent patients, clinicians should be advised about the risk of 
development of psychotic symptoms. The presence of some psychotic symptoms 
could increase the potential risks of disturbing behaviours. 
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1. Introduction 
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Cocaine consumption in Europe has been increasing, achieving a higher prevalence 
than in the United States, although a mild stabilization has been detected in 
recent years (European Monitoring Centre for Drugs Addiction, 2012; United 
Nations Office on Drug and Crime, 2012). Comorbidity of cocaine use disorders 
with psychiatric disorders has been extensively reported (Brady et al., 1991; Satel 
and Edell, 1991; Barlett et al., 1997; Kalayasiri et al., 2006a; Tang et al., 2007; 
Herrero et al., 2008; Roncero et al., 2012; Roncero et al., 2013a). One of the most 
serious co-morbidities with cocaine use disorders is the presence of psychotic 
symptoms. Cocaine-Induced Psychotic Disorder (CIPD) has been found in 5% of 
young cocaine users (Herrero et al., 2008), and in cocaine dependent patients 
treated in therapeutic community, the prevalence of CIPD was 11.5% (Vergara-
Moragues et al., 2012). In clinical settings, psychotic symptoms have been found 
to occur in between 29% and 86.5% of cocaine-dependent patients (Brady et al., 
1991; Satel and Edell, 1991; Barlett et al., 1997; Kalayasiri et al., 2006a; Tang et 
al., 2007; Roncero et al., 2012; Vorspan et al., 2012, Roncero et al., 2013a), but 
actual figures remain unclear because the samples are not similar, and the 
instruments and approach used in the evaluation process are not comparable 
(Roncero et al., 2012). 
 
There is a controversy between the diagnosis of psychotic symptoms secondary 
to cocaine intoxication and the DSM-IV diagnosis of CIPD (Boutros and Bowers, 
1996; Caton et al., 2007). Some authors, after studying psychotic symptoms in 
cocaine users, classified the induced psychotic episodes in two types. The first, 
called “transient psychotic episodes”, is experienced during consumption. In this 
case, the symptoms are gone after a binge or a crash phase. The other type is 
named “persistent psychotic episodes”, in which the psychotic symptomatology can 
persist for as long as days after a crash phase and the severity of the symptoms is 
higher than in transient psychotic symptoms. This type is considered authentic 
CIPD (Satel and Edell, 1991). 
The DSM-IV describes substance-induced psychotic disorders as being associated 
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with prominent hallucinations or delusions and specifies that hallucinations should 
not be included if the person has insight that they are substance induced. They also 
should not be included when there is evidence that the symptoms developed 
during or within a month of substance intoxication. This diagnosis should be made 
instead of a diagnosis of substance intoxication only when the symptoms are 
sufficiently severe to warrant independent clinical attention. The criteria between 
substance-induced psychotic disorders and substance intoxication are 
differentiated as the duration of symptoms, their severity and hallucinations occur 
in the absence of intact reality testing. There are some criticisms about the narrow 
definition of CIPD, and this has led to the suggestion of a broader classification 
based on association rather than causation for DSM-5 (Mathias et al., 2008). 
Cocaine-induced psychosis (CIP) has been suggested for psychotic symptoms 
related to cocaine use (Brady et al., 1991; Satel and Edell, 1991; Roncero et al., 
2012). 
 
Some risks factors are associated with transient psychosis related to cocaine use: 
amount of cocaine consumed (Floyd et al., 2006; Kalayasiri et al., 2006a; Mahoney 
et al., 2008; Vorspan et al., 2012; Roncero et al., 2013a), age of onset of use 
(Cubells et al., 2005; Kalayasiri et al., 2006a; Floyd et al., 2006; Kalayasiri et al., 
2010; Vorspan et al., 2012) and co-morbidity with attention deficit hyperactivity 
disorder (ADHD) (Tang et al., 2007; Roncero et al, 2013b). With respect to 
borderline personality disorder (BPD), antisocial personality disorder (APD) 
(Kranzler et al., 1994; Roncero et al., 2013a) and drug use (smoked or 
intravenous) (Mooney et al., 2006, Kalayasiri et al., 2006b; Vorspan et al., 2012; 
Roncero et al., 2013c), the association remains unclear. Some authors have linked 
psychotic symptoms with these variables, but others reject these associations. The 
clinical factors associated with transient cocaine-induced psychotic symptoms are 
well-described in the current literature, but studies about the clinical factors 
associated with CIPD are lacking. 
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Therefore, knowledge of the clinical features of cocaine-dependent patients who 
have developed transient psychotic symptoms or CIPD may be relevant not only 
for diagnostic information but also for evaluating therapeutic interventions to be 
applied in each case. 
 
The aim of this study is to compare the clinical characteristics of three groups 
of patients in treatment for cocaine dependence: patients without any psychotic 
symptoms (NS), patients with transient psychotic symptoms (PS) and patients 
with CIPD. We hypothesized that there is a gradient of severity in which the 
presence of PS is more severe than NS, and the presence of CIPD is more severe 
than both NS and PS. 
 
2. Methods 
2.1. Design 
We used a cross-sectional design in an observational study. Patients were 
assessed during two visits. Initially, patients were evaluated by a psychiatrist, 
who collected demographic and consumption data, and (if applicable) gave a 
diagnosis of cocaine dependence disorder according to DSM-IV-TR criteria. 
Subsequently, they were interviewed by a psychologist trained in the 
administration of the diagnostic interview described below. 
 
2.2. Sample 
The 150 participants were patients undergoing treatment at the Drug Unit of 
the Department of Psychiatry at the University Hospital Vall d'Hebron in Barcelona 
(Spain) between February 2007 and August 2010. Inclusion criteria included 
being over 18 years of age, having a diagnosis of cocaine dependence and 
following a treatment regimen as an outpatient or an inpatient at the drug unit of 
the hospital. Each patient signed the corresponding informed consent approved by 
the ethics committee of the hospital and received no financial compensation for 
their participation.  
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Exclusion criteria included the presence of primary psychotic or bipolar I disorders, 
being intoxicated at the time of the interview, having severe somatic disorders 
and not sufficient language proficiency.  
 
According to these criteria, one patient was not evaluated because they came 
intoxicated to the evaluation visit. Seven patients were excluded due to the 
existence of a primary psychotic disorder. The total sample of the study was 
composed of 143 patients. 
 
2.3. Assessments and measures 
In addition to socio-demographic and consumption variables, the Spanish Version of 
the Psychiatric Research Interview for Substance and Mental Disorders (PRISM) 
(Torrens et al, 2004; Hasin et al., 1996) was administered. This interview, based on 
DSM-IV, diagnoses approximately 20 Axis I and II disorders. It was designed 
specifically to differentiate primary mental disorders and induced effects of 
intoxication and withdrawal in subjects with high consumption of alcohol and 
other substances. The main feature of this instrument is to add specific guidelines 
for evaluation and classification requirements such as frequency, duration of 
symptoms and explicit exclusion criteria, to determine the temporal relationship 
between psychiatric symptoms and substance use. According to the psychotic 
disorders section of the instrument, the sample was divided into three study 
groups. In Group I, the patients had no psychotic symptoms (NS) in their lifetime. 
In Group II, the patients had psychotic symptoms but were aware that these 
symptoms were caused by substance use (PS) in their lifetime. In Group III, patients 
had psychotic symptoms and were not aware that they were caused by substance 
(CIPD) in their lifetime. Finally, we included the cocaine-induced psychosis group 
(CIP) if a patient were included in the PS or CIPD groups. According to PRISM 
criteria, to diagnose CIPD the delusions have to be clear, they have to last more 
than 1 h and disagree with the cultural context of the patients.  
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To diagnose hallucinations, they have to be clear, last more than 1 h and disagree 
with the cultural context of the patients, but they do not have to be present while the 
patients are sleeping or awake; additionally, the patients have to act according to the 
hallucinations. 
 
2.4. Statistical analysis 
As psychotic symptoms were included in the definition of study groups, they were 
simply described in terms of frequencies. ANOVA and Chi-square tests  where 
used to compare the socio-demographic and clinical characteristics of the sample 
and comorbidities between study groups. The Chi-square test was considered not 
applicable, due to insufficient representation in the sample, when at least one cell 
content was less than 5. 
 
To reduce the presence of some false positive effects, Bonferroni corrections 
for multiple tests were performed grouping socio-demographic and comorbidity 
variables. Only  the variables  that  exceeded  the respective  p values  were entered 
in  a second analysis. These variables were used in a multivariate multinomial 
regression analysis as predictors, using stepwise entrance of variables to perform an 
exploratory analysis including a polynomial variable including CIPD, PS or NS as 
dependent variables. To provide information on the adjustment of the resulting 
model, sensitivity (capacity to detect subjects among categories) and specificity 
(capacity to detect subjects not included in categories) parameters were reported. 
All statistical tests were two-tailed. SPSS Version 18.0 for Windows was used in all 
analyses. 
 
3. Results 
Of the 143 participants, 46 patients (32.1%) in the sample did not report any 
psychotic symptoms, 97 (67.9%) presented with a history of any cocaine-
induced psychotic symptom, 39 (27.3%) were included in the PS group and 58 
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(40.6%) in the CIPD group. Socio-demographic data were collected, as shown in 
Table 1. Statistically significant differences among study groups where found in 
the following variables: age at onset of cocaine addiction, duration of dependence, 
imprisonment and completion of primary studies. 
 
We found that 37.1 % of the sample presented three or more substance use 
disorders, and comorbidities can also be observed in Table 1. Regarding other 
substances, cannabis, alcohol and hallucinogens were found to be statistically 
significant. No significant differences in Axis I disorder analysis was found. 
Differences that were statistically significant for both Axis II disorders (antisocial 
and borderline personality disorders) were found, but they were no longer 
statistically significant following the Bonferroni corrections. 
 
Table 1. Sociodemographic and comorbities clinical data 
  
Total 
N=143 
 
NS N=46 
(32,1%) 
 
PS N= 39 
(27.3%) 
 
CIPD 
N= 58 (40.6%) 
 
 
 
Significance 
N %/SD N 
%/S 
D N 
%/S 
D N %/SD 
Age (years) 
 
34.28 8.01 35.74 
7.2 5 
35.21 
8.7 9 32.5 
0 7.83 
F 
=2.504 
p=0.085 
Sex (men) 
 
117 81.8 38 82.6 29 74.4 50 86.2 
2
=2,2 
29 
p=0.328 
Marital status Single 81 56.6 24 52,2 23 59 34 58,6 
2
=6.0 
42 
p=0.196 
Couple 36 25.2 17 37,0 8 20,5 11 19 
Divorced 26 18.2 5 10,9 8 20,5 13 22,4 
Not finished primary 
studies 
 
29 20.3 3 10.3 12 41.4 14 24.6 na 
Active (employed or 
studying) 
 
60 42.0 20 33.3 18 30 22 36,7 
2
=0.7 
12 
p=0.071 
Living alone  16 11.3 3 6.5 5 12.8 8 14 na 
Ever imprisoned 
 
66 46.2 11 23.9 24 61.5 31 53.4 
2
=.14. 
112 
p=0.001 
Age at onset of 
addiction (years) 
 
24.78 7.44 27,74 
6.4 1 
25.72 
8.2 4 21.7 
9 6.60 
F=9.65 
6 p<0.0001 
Duration of dependence 
(years) 
 
7.69 6.97 5.67 
5.8 4 
6.85 
5.8 2 
9.84 7.95 
F=5.26 
7 p=0.006 
Grams consumed/ week 
last month 
 
3.66 8.30 2.69 
6.8 0 
2.19 
4.5 2 
5.61 11.08 
F=2.04 
5 
p=0.134 
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Nasal airway 
 
110 88 60 95 32 88.9 40 81 
2
=3.7 
64 
p=0.152 
Lifetime SUD (Abuse or 
dep.) Opiates 33 23.1 8 17.4 8 20.5 17 29.3 

2
=2.2 
52 
p=0.324 
Alcohol 109 76.2 27 58.7 32 82.1 50 86.2 
2
=11. 
719 
p=0.003 
Sedative 25 17.5 4 8.7 7 17.9 14 24.1 
2
=4.2 
49 
p=0.120 
         

 
Cannabis 64 44.8 9 19.6 19 48.7 36 62.1 
2
=19. 
085 
p<0.0001 
Other 
stimulants 23 16.1 5 10.9 5 12.8 13 22.4 

2 
2.956 
p= 0.228 
Hallucino 
gens 41 28.7 5 10.9 9 23.1 27 46.6 

2
=16. 
792 
p<0.0001 
Lifetime any SUD (ex. 
cocaine)* 
 
119 83.2 29 63.0 36 92.3 54 93.1 
2
=19. 
771 
p<0.0001 
Lifetime  axis I Major 
depressio n 
 
19 
 
13.3 
 
9 
 
19.6 
 
4 
 
10.3 
 
6 
 
10.3 
2
=2.3 
20 
 
p=0.313 
Anxiety 
disorder 6 4.2 4 8.7 1 2.6 1 1.7 na 
 
 
ADHD 
 
42 
 
29.4 
 
11 
 
23.9 
 
8 
 
20.5 
 
23 
 
39.7 
 

2
=5.0 
 
childhood 93 p=0.078 
Eating 
disorders 
 
7 
 
4.9 
 
2 
 
4.3 
 
3 
 
7.7 
 
2 
 
3.4 
 
na 
 
Substance 
 
40 
 
28.0 
 
9 
 
19.6 
 
13 
 
33.3 
 
18 
 
31 
 

2
=2.4 
40 
p=0.295 
Induced 
mood 
disorder 
Lifetime any axis I  66 46.2 21 45.7 19 48.7 26 44.8 

2
=0.1 
49 
p=0.928 
Lifetime axis II 
Antisocial 
(APD) 22 
 
34 
15.4 
 
23.8 
3 
 
8 
6.5 
 
17.4 
4 
 
6 
10.3 
 
15.4 
15 
 
20 
25.9 
 
34.5 

2
=8.4 
55 
p=0.015 

2
=6.2 
19 
p=0.045 
Borderlin e 
(BPD) 
Lifetime any axis II  44 30.8 10 21.7 10 25.6 24 41.4 

2
=5.3 
07 
p=0.07 
NS. No psychotic symptoms PS.- Psychotic Symptoms CIPD.- Cocaine Induced Psychotic Disorder. 
Disorders were described when at least 5 patients met criteria. Na. Chi Square test was considered 
not applicable when one or more of the cells had an unexpected count less than 5 
-*This includes any substance moreover of those presented above.- Miinum significance after 
bonferroini adjustment: Co-morbidities data: 0.05/14= 0.0036, Sociodemographic data: 0.05/9 = 
0.006.  
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Delusions and hallucinations in the PS and CIPD groups are described in Table 2. 
 
 
Table 2. Hallucinations and Delusions  
 Total 
N= 97 
(67.95%) 
PS N= 39 
(27.3%) 
CIPD 
N= 58 
(40.6%) 
 
N % 
 
N % 
 
N % 
Delusions   
Self-referential  25 17.5 13  33.3 25  43.1 
Persecution  50 35 7  17.9 50  86.2 
Grandiosity  3 2.1  -  3 5,2 
Somatic  2 1.4  -  2 3,4 
Depressant  -   -  - 
Jealous  11 7.7  -  11  19.0 
Bizarre  1 1.7  -  1 1.7 
Hallucinations   
Auditive no insight 4 2.8 -   4 6,9 
 insight* 51 35.7 22  56,4 29 50 
Visual no insight 5 3.5 -   5 8.6, 
 insight* 55 38.5 28  71,8 27  46.6 
Tactile no insight 3 2,1 -   3 5,2 
 insight* 42 29.4 17  43,6 25  43,1 
Olfactory no insight 2 1.4 -   2 3.4 
 insight* 8 5.6 3  7.7 5 8,6 
Ps Psychotic Symptoms CIPD Cocaine induced psychotic disorder  
* The symptom was present but the subject was aware that it was induced by drug use. 
 
 
The multinomial regression model using stepwise entrance of variables was conducted 
to analyse all variables from the previous bivariate analysis that remained statistically 
significant after Bonferroni correction. These variables included lifetime alcohol  use, 
cannabis and hallucinogens abuse or dependence, age at onset, years of dependence and 
history of imprisonment. The resulting model was statistically significant (2=52.486, 
p<0.0001), with the R2 higher for the first model (Cox=0.307). Sensibility was 71.7% 
for the NS group, 30.8% for the PS group and 77.6% for the CIPD group. Specificity 
was 35.0% for the NS group, 13.3% for the PS group and 51.7% for the CIPD group. 
 
Imprisonment was found to be significantly more frequent in the PS than the NS group. 
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The distribution of age at onset of dependence, lifetime cannabis abuse or dependence 
and imprisonment were significantly different between the NS and CIPD groups. 
Finally, no statistically significant differences were found between PS and CIPD (see 
table 3). 
 
Table 3. Multinomial Regression 
 
PS vs. NS  CIPD vs. NS CIPD vs. PS 
W Sig O ald
 . R 
95% 
IC 
 W Sig O ald
 . R 
95% 
IC 
W Sig O ald
 . R 
95% 
IC 
Age onset of depende nce  
4.4 
93 
 
0.0 
34 
 
0.9 
28 
 
0.8 
65 
 
0.9 
94 
 
3.1 
56 
 
0.0 
76 
 
1.0 
61 
 
0.9 
94 
 
1.1 
33 
Duratio n of depende nce  
3.3 
55 
 
0.0 
67 
 
1.0 
64 
 
0.9 
96 
 
1.1 
37 
 
Alcohol   
Cannab is 0.0 
21 
0.0 
87 
0.3 
82 
0.1 
27. 
1.1 
49 
4.3 
45 
0.0 
37 
0.3 
22 
0.1 
11 
0.9 
35 
 
Halluci nogens   
Ever impriso 
ned 
8.1 
53 
0.0 
04 
0.2 
43 
0.0 
92 
0.6 
42 
4.1 
81 
0.0 
41 
0.3 
66 
0.1 
40 
0.9 
59 
 
 
 
4. Discussion 
The present study describes the presence of psychotic symptomatology in 
cocaine- dependent subjects and explores the relationship between cocaine-induced 
psychotic disorder and clinical features. Of the total sample, 67.9% of the subjects 
presented with a history of any cocaine-induced psychotic symptomatology, as 
determined by the presence of a positive item in the PRISM interview. These 
results are consistent with other clinical sample studies reporting a prevalence 
between 29% and 86.5% (Manschreck et al., 1988; Brady et al., 1991; Satel and 
Edell, 1991; Barlett et al., 1997; Kalayasiri et al., 2006a; Tang et al., 2007; Vorspan 
et al., 2012; Roncero et al., 2013a, Roncero et al., 2013b). PRISM has never been 
used to study CIPD in cocaine- dependent patients who are seeking treatment in 
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outpatient clinics; therefore, the results are difficult to compare. 
 
The 40% of CIPD, as diagnosed by the PRISM interview is very high if the results 
are compared with a sample of cocaine-dependent patients seeking treatment in a 
therapeutic community (11.5%) (Vergara-Morales et al., 2012; Vergara-Moragues et 
al., 2013) and from cocaine users recruited outside the health-care services (5%) 
measured with the same instrument (Herrero et al., 2008). Differences compared 
with the patients from the therapeutic community may be because patients who 
are able to adhere to therapeutic community treatment tend to have less 
psychopathology compared with patients who leave treatment (De Leon et al., 
1973; Ravndal, 1991; Vergara-Moragues et al., 2012). Recent studies have 
demonstrated that there is a higher treatment success (measured by length of stay 
in days, type of discharge and therapeutic community outcome clinical 
impression) among people without psychopathological comorbidity (Vergara-
Moragues et al., 2013). Furthermore, in the sample of Vergara-Moragues et al. 
(2012), the PRISM interview was administered after 15-20 days in the 
therapeutic community, and these patients may be more severe, with a higher 
prevalence of subjects with cocaine (or other)-induced psychotic disorders who 
dropped out of the treatment in the first 15-20 days. Additionally, the higher 
prevalence of CIPD reported in the study with regular cocaine users who are 
seeking treatment also evaluated with PRISM (Herrero et al., 2008) may be due 
to the sample characteristics.  
 
We studied cocaine- dependent patients who are seeking treatment in a health 
centre of a general hospital, whereas the other study was conducted with 
cocaine users not seeking treatment. However, to confirm our findings, it would 
be interesting to perform another study in another clinical sample seeking treatment. 
PRISM was used in this study because it is a precise instrument to differentiate 
between primary psychotic disorders and those induced by substances. For this 
reason and following the DSM-IV criteria, patients with hallucinations that are 
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recognized as caused by the consumption of the drug are not included in the 
group of CIPD. This could explain why one-third of patients who experience 
only psychotic symptoms associated with cocaine consumption (PS) cannot be 
diagnosed with a CIPD following the PRISM criteria. In our sample, the CIPD 
group was not aware that these perceptions are caused by consumption and they 
behaved accordingly with them. 
 
Factors related with the risk of having only induced PS or CIPD are not well 
known (Roncero et al., 2012; Roncero et al., 2013a). It has been hypothesized that 
the existence of clinical psychotic disorders slows or reduces the risk of developing 
cocaine dependence (Brousse et al., 2010). In our sample, CIPD presence is 
associated with a lower age of onset of addiction, more years of duration of 
addiction and a history of imprisonment. 
 
Our results regarding the younger age of onset of cocaine dependence confirm 
previous studies (Barlett et al., 1997; Cubells et al., 2005; Kalayasiri et al., 2006a; 
Floyd et  al., 2006; Lichlyter et al., 2011). The lower onset age is in the CIPD 
group in comparison with the PS group, whereas those with a later onset of 
cocaine addiction are mostly in the NS group, and this lower onset age is 
consistent with the previous literature. Additionally, the number of years of 
regular cocaine use has been described previously in other studies (Brady et al., 
1991; Roncero et al., 2013a; Lichlyter et al., 2011). However, these two factors 
(years of regular use and age of onset of cocaine dependence) can be linked. 
 
Patients with only psychotic symptoms (61.5%) have a higher history of 
imprisionment than patients without any psychotic symptoms (23.9 %) or patients 
of the CIPD group (53.4%). This may be because consumption could be linked to 
hostile behaviours. It has been suggested that stimulant use could generate 
psychotic symptoms that manifest as hostility. These symptoms contributes to a 
perception of the environment as hostile and a threatening place as well as 
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increasing impulsivity. The cocaine-induced psychotic symptoms trigger hostile 
behaviours (Tang et al., 2007; Lapworth et al., 2009). This finding allows us to 
affirm that the presence of psychotic symptomatology could be a criterion for 
severity of cocaine dependence because even patients who do not meet the criteria 
for CIPD and preserve their view of reality may have behavioural disorders. 
However, patients in the PS group have a more prominent history of arrest than 
the CIPD group, and it could be hypothesized that patients with PS end up in jail and 
CIPD end up in the hospital. However, this hypothesis should be tested so that one 
may link the time in which the patients had taken the substance and have been 
imprisoned or confined to the hospital. Furthermore, we find a lower average 
occurrence of imprisonment in the CIPD group even though there is a higher 
average occurrence of antisocial personality disorder (25.9 %) compared with the PS 
group (10.3%). 
 
CIPD is also associated with cannabis, hallucinogen and alcohol use disorders. 
The psychotic symptoms association with cannabis use disorder is consistent with 
preliminary reports that showed an association with cannabis use (Kalayasiri et 
al., 2010) or cannabis dependence (Roncero et al., 2013a). Additionally, adolescent 
onset of cannabis use has been described as increasing the risk of having psychotic 
symptoms in cocaine-dependent individuals (Kalayasiri et al., 2010), and this 
seems to confirm our results. 
 
We described the presence of psychotic symptoms in association with the 
consumption of hallucinogens. However, we must be very cautious in 
interpreting this finding because hallucinogen use obviously caused hallucinations 
(Assad and Shapiro, 1986; Paparelli et al., 2011). 
 
Further, the alcohol-induced psychotic syndrome is well known, with a lifetime 
prevalence of 0.5%. It has been described that this is related to a younger age of 
onset of alcohol dependence (Perala et al., 2010), so it could explain our finding 
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regarding the association of CIPD with alcohol-use disorders. 
 
When reviewing literature in reference to the relationship with other Axis I 
mental disorders, it is noted that some studies conclude that there has been a 
relationship between psychotic disorders and any mental disorders in cocaine-
dependent patients. Unlike previous studies associating it with adult ADHD 
(Manschreck et al., 1988; Tang et al., 2007; Roncero et al., 2013b), we failed to 
detect any relationship between psychotic symptoms and ADHD in childhood. 
This difference could be because we measured only childhood ADHD in the 
current study because the ADHD adult section of PRISM has been validated 
recently (Ramos-Quiroga et al., 2012). Furthermore, in another study by our 
research group we failed to detect an association between adult ADHD and any 
psychotic disorder in cocaine-dependent adults (Daigre et al., 2013). 
Co-morbid Axis II disorders are prevalent in cocaine users. Several studies found 
prevalences ranging from 30 to 70% in inpatient samples, with antisocial (ASPD) 
and borderline personality disorders being the most frequent. Regarding Axis II 
disorders, the presence of psychotic symptoms was not associated with 
personality disorders (Kranzel et al., 1994). In the sample, neither the presence of 
psychotic symptoms nor cocaine-induced psychotic disorder is associated with any 
personality disorders, although it should be noted that there is a tendency, and it 
seems to be a gradient of ASPD: CIPD group (25.9%), PS group (10%) and NS 
group (6.5%). This is consistent with previous work associated with the coexistence 
of ASPD in a clinical population in treatment (Vergara-Moragues et al., 2012; 
Roncero et al., 2013a). However, this point should be re-studied in the future. 
 
In the present study, we hypothesized that there is a gradient of severity in which 
the presence of PS is more severe than NS, and the presence of CIPD is more 
severe than both NS and PS. After obtaining the results, we conclude that the 
hypothesis is only partially confirmed because following the results of multivariate 
analysis, the NS group presents less severity than the PS and CIPD groups, but 
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there were no statistically significant differences between patients with PS and 
CIPD. 
 
The similarities between the PS and CIPD groups are probably due to them 
sharing severity factors associated with present symptoms, regardless of intensity, 
which would be a common first step. For these reasons, those who present with PS 
or CIPD tend to have grater severity of addiction, expressed a younger age of onset 
of dependence and greater comorbidity with other addictions and personality 
disorders. We probably failed to find differences between PS and CIPD in the 
multivariate analysis because development of the full disorder could be associated 
with other factors such as genetic influence or even the phase the disease during 
evaluation. Thus, these factors should be researched in future studies. Regardless, 
the most important step for clinicians is to be able to identify CIP; clinically, it is 
less relevant to differentiate between people who meet diagnostic criteria of CIPD 
and those who do not. 
 
Cautious clinical management of an addict patient with psychotic symptomatology 
is necessary to discern in which cases the mental disorder is independent of 
substance use and when it is induced by the drug. It is also necessary to then 
differentiate between the full syndrome and only the presence of symptoms. The 
process is complex because during both intoxication and withdrawal, psychotic 
symptoms may occur. 
 
One of the strong points of this study is the use of PRISM as a PS and CIPD 
evaluation instrument, as diagnoses using this instrument are very 
comprehensive. Previously, PRISM has been used to study outcomes over two 
years among patients admitted to emergency departments with early-phase 
primary or substance-induced psychosis (Drake et al., 2011), but there are no 
others studies using PRISM in cocaine-dependent patients seeking treatment. 
Comparing the subjects in the PS and CIPD groups with those patients without 
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any symptoms could lead to the identification of the sickest patients: the PS and 
CIPD groups are more often composed of poly-drug users, they have an early 
cocaine addiction onset, and the years of duration of dependence are longer and 
they have more of a criminal background than the NS group. These are 
indicative of the severity of addiction when assessing patient’s severity. 
 
Limitations of the study should be noted. We included in the analyses the amount 
of cocaine and the route used, but we did not consider the time in which this 
consumption contributes to psychotic symptoms. This should be considered in the 
design of future studies. 
 
This paper shows that both the presence of CIPD diagnosed by the PRISM 
interview and the only presence of PS are very common in cocaine-dependent 
patients. There are differences between patients who develop a clinically isolated 
and complete syndrome. Those who develop the full syndrome are more severe, as 
they have begun poly-drug use and have an earlier onset of addiction and the 
addiction has lasted longer. Moreover, patients with PS are proven to have major 
legal problems. Regardless, the most important step for clinicians is to be able to 
identify CIP. 
The high frequency of CIPD or PS in cocaine-dependent patients seeking 
treatment should be noted. Furthermore, the presence of some psychotic symptoms 
could increase the potential risks of a disturbing behaviour, posing a threat to the 
patients themselves and/or others. Clinicians should be advised about the risk of 
developing psychotic symptoms in cocaine-dependent patients. 
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